Research Programs - Results
Since its inception, the MMRF has supported the development of more than 40 potential treatments. Today, excitingly, 15 of those are being evaluated in clinical trials. This support has come from research grants to further pre-clinical validation efforts (as indicated by an acorn), Biotech Investment Awards (as indicated by a “B”) to expand validation and early clinical trials, and/or MMRC Phase I and II clinical trials (as indicated by a star). Continued investment in these programs represents our commitment to bringing patients the next generation of treatments as quickly as possible.